Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
50.5M
-
Number of holders
-
107
-
Total 13F shares, excl. options
-
20.1M
-
Shares change
-
-547K
-
Total reported value, excl. options
-
$307M
-
Value change
-
-$10M
-
Number of buys
-
53
-
Number of sells
-
-50
-
Price
-
$15.26
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q2 2018
124 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q2 2018.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.1M shares
of 50.5M outstanding shares and own 39.78% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.72M shares), VANGUARD GROUP INC (2.27M shares), DIMENSIONAL FUND ADVISORS LP (1.77M shares), FEDERATED INVESTORS INC /PA/ (1.28M shares), STATE STREET CORP (1.01M shares), TEACHERS ADVISORS, LLC (563K shares), NORTHERN TRUST CORP (454K shares), Bank of New York Mellon Corp (408K shares), Cortina Asset Management, LLC (392K shares), and GEODE CAPITAL MANAGEMENT, LLC (381K shares).
This table shows the top 107 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.